Testing effectiveness (Phase 2)Study completedNCT02285920
What this trial is testing
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Who this might be right for
End-Stage Renal Disease
University of Pennsylvania 129